About
Brian Culley is a biotechnology executive and current Chief Executive Officer of Lineage Cell Therapeutics, a clinical-stage cell therapy company. Before joining Lineage in September 2018, he served as interim CEO of Artemis Therapeutics and earlier as CEO and board member of Mast Therapeutics until Mast's 2017 merger with Savara. His background spans business development, technology transfer, and drug-development research, with a career focused on life sciences and regenerative medicine.
Areas of interest
biotechcell therapyregenerative medicinedrug developmentcorporate partneringophthalmologyneurologyoncology